Review





Similar Products

99
New England Biolabs rna fragments
Transcriptome-wide mapping and biochemical characterization of RhsP2 <t>RNA</t> recognition and ADP-ribosylation. ( A ) Schematic of the eCLIP-seq workflow used to map RhsP2-associated RNAs. Cells expressing FLAG-tagged, catalytically inactive RhsP2* were UV-crosslinked, lysed, and subjected to anti-FLAG immunoprecipitation. Crosslinked RNA fragments associated with RhsP2* were recovered following SDS–PAGE separation, converted into complementary DNA (cDNA) libraries containing unique molecular identifiers, and sequenced. ( B ) Representative genome-browser view of RhsP2* eCLIP-seq signal at a target locus. IP and matched input tracks are shown. The shaded region highlights a representative RhsP2*-enriched peak, with the local sequence shown below. ( C ) Genomic annotation of RhsP2* eCLIP-seq peaks across transcript features. The bar plot shows the fraction of called peaks assigned to CDSs, 5′ UTRs, 3′ UTRs, tRNAs, sRNAs, rRNAs, and intergenic regions. ( D ) De novo motif analysis of RhsP2* eCLIP-seq peaks. Two enriched UAA-centered motifs identified from RhsP2* eCLIP-seq peaks are shown, including a highly enriched UAAG-containing motif. The percentage of peaks containing each motif and the associated enrichment P -value are shown. ( E ) Schematic of the Cy3-labeled synthetic RNA substrate used for biochemical validation and site-mapping experiments. The UAAG motif is highlighted in green, and nucleotide positions used for <t>RNase</t> T1 and alkaline hydrolysis (AH) mapping are indicated. ( F ) Biochemical evaluation of motif-dependent RNA recognition and modification. Top, EMSA evaluating the binding of catalytically inactive RhsP2* to RNA substrates containing the indicated motif variants. RNA substrates were incubated with increasing concentrations of purified RhsP2* (0–10 µM). Free RNA and protein-bound RNA species are indicated. Bottom, in vitro ADP-ribosylation of the corresponding RNA substrates. Reactions were performed with 1 mM NAD⁺ in the absence or presence of 0.1 µM purified WT RhsP2 for 10 s, and reaction products were resolved by denaturing urea-PAGE. Unmodified RNA and slower-migrating ADP-ribosylated RNA (ADPr-RNA) species are indicated. ( G ) AH and RNase T1 mapping of purified ADPr-RNA. Unmodified control RNA (Ctrl) and ADPr-RNA were subjected to AH, and RNase T1 digestion was used as a nucleotide reference ladder. The red AH label denotes the AH lane generated from ADPr-RNA. The green bar marks the UAAG-containing region that is protected from alkaline cleavage following ADP-ribosylation. Numbers indicate nucleotide positions within the synthetic RNA substrate shown in panel (E).
Rna Fragments, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kinase/T4+Polynucleotide+Kinase/pmc13768812-177-9-18
Average 99 stars, based on 1 article reviews
rna fragments - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

97
Cell Signaling Technology Inc amp activated protein kinase α ampkα
Transcriptome-wide mapping and biochemical characterization of RhsP2 <t>RNA</t> recognition and ADP-ribosylation. ( A ) Schematic of the eCLIP-seq workflow used to map RhsP2-associated RNAs. Cells expressing FLAG-tagged, catalytically inactive RhsP2* were UV-crosslinked, lysed, and subjected to anti-FLAG immunoprecipitation. Crosslinked RNA fragments associated with RhsP2* were recovered following SDS–PAGE separation, converted into complementary DNA (cDNA) libraries containing unique molecular identifiers, and sequenced. ( B ) Representative genome-browser view of RhsP2* eCLIP-seq signal at a target locus. IP and matched input tracks are shown. The shaded region highlights a representative RhsP2*-enriched peak, with the local sequence shown below. ( C ) Genomic annotation of RhsP2* eCLIP-seq peaks across transcript features. The bar plot shows the fraction of called peaks assigned to CDSs, 5′ UTRs, 3′ UTRs, tRNAs, sRNAs, rRNAs, and intergenic regions. ( D ) De novo motif analysis of RhsP2* eCLIP-seq peaks. Two enriched UAA-centered motifs identified from RhsP2* eCLIP-seq peaks are shown, including a highly enriched UAAG-containing motif. The percentage of peaks containing each motif and the associated enrichment P -value are shown. ( E ) Schematic of the Cy3-labeled synthetic RNA substrate used for biochemical validation and site-mapping experiments. The UAAG motif is highlighted in green, and nucleotide positions used for <t>RNase</t> T1 and alkaline hydrolysis (AH) mapping are indicated. ( F ) Biochemical evaluation of motif-dependent RNA recognition and modification. Top, EMSA evaluating the binding of catalytically inactive RhsP2* to RNA substrates containing the indicated motif variants. RNA substrates were incubated with increasing concentrations of purified RhsP2* (0–10 µM). Free RNA and protein-bound RNA species are indicated. Bottom, in vitro ADP-ribosylation of the corresponding RNA substrates. Reactions were performed with 1 mM NAD⁺ in the absence or presence of 0.1 µM purified WT RhsP2 for 10 s, and reaction products were resolved by denaturing urea-PAGE. Unmodified RNA and slower-migrating ADP-ribosylated RNA (ADPr-RNA) species are indicated. ( G ) AH and RNase T1 mapping of purified ADPr-RNA. Unmodified control RNA (Ctrl) and ADPr-RNA were subjected to AH, and RNase T1 digestion was used as a nucleotide reference ladder. The red AH label denotes the AH lane generated from ADPr-RNA. The green bar marks the UAAG-containing region that is protected from alkaline cleavage following ADP-ribosylation. Numbers indicate nucleotide positions within the synthetic RNA substrate shown in panel (E).
Amp Activated Protein Kinase α Ampkα, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kinase/AMPKalpha+Antibody/pmc12811471-130-16-22
Average 97 stars, based on 1 article reviews
amp activated protein kinase α ampkα - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc phosphorylated adenosine monophosphate activated protein kinase
Transcriptome-wide mapping and biochemical characterization of RhsP2 <t>RNA</t> recognition and ADP-ribosylation. ( A ) Schematic of the eCLIP-seq workflow used to map RhsP2-associated RNAs. Cells expressing FLAG-tagged, catalytically inactive RhsP2* were UV-crosslinked, lysed, and subjected to anti-FLAG immunoprecipitation. Crosslinked RNA fragments associated with RhsP2* were recovered following SDS–PAGE separation, converted into complementary DNA (cDNA) libraries containing unique molecular identifiers, and sequenced. ( B ) Representative genome-browser view of RhsP2* eCLIP-seq signal at a target locus. IP and matched input tracks are shown. The shaded region highlights a representative RhsP2*-enriched peak, with the local sequence shown below. ( C ) Genomic annotation of RhsP2* eCLIP-seq peaks across transcript features. The bar plot shows the fraction of called peaks assigned to CDSs, 5′ UTRs, 3′ UTRs, tRNAs, sRNAs, rRNAs, and intergenic regions. ( D ) De novo motif analysis of RhsP2* eCLIP-seq peaks. Two enriched UAA-centered motifs identified from RhsP2* eCLIP-seq peaks are shown, including a highly enriched UAAG-containing motif. The percentage of peaks containing each motif and the associated enrichment P -value are shown. ( E ) Schematic of the Cy3-labeled synthetic RNA substrate used for biochemical validation and site-mapping experiments. The UAAG motif is highlighted in green, and nucleotide positions used for <t>RNase</t> T1 and alkaline hydrolysis (AH) mapping are indicated. ( F ) Biochemical evaluation of motif-dependent RNA recognition and modification. Top, EMSA evaluating the binding of catalytically inactive RhsP2* to RNA substrates containing the indicated motif variants. RNA substrates were incubated with increasing concentrations of purified RhsP2* (0–10 µM). Free RNA and protein-bound RNA species are indicated. Bottom, in vitro ADP-ribosylation of the corresponding RNA substrates. Reactions were performed with 1 mM NAD⁺ in the absence or presence of 0.1 µM purified WT RhsP2 for 10 s, and reaction products were resolved by denaturing urea-PAGE. Unmodified RNA and slower-migrating ADP-ribosylated RNA (ADPr-RNA) species are indicated. ( G ) AH and RNase T1 mapping of purified ADPr-RNA. Unmodified control RNA (Ctrl) and ADPr-RNA were subjected to AH, and RNase T1 digestion was used as a nucleotide reference ladder. The red AH label denotes the AH lane generated from ADPr-RNA. The green bar marks the UAAG-containing region that is protected from alkaline cleavage following ADP-ribosylation. Numbers indicate nucleotide positions within the synthetic RNA substrate shown in panel (E).
Phosphorylated Adenosine Monophosphate Activated Protein Kinase, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kinase/Phospho-AMPKalpha+(Thr172)+Antibody/pmc12811436-71-41-48
Average 96 stars, based on 1 article reviews
phosphorylated adenosine monophosphate activated protein kinase - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

86
Cell Signaling Technology Inc protein kinase b
Resistance exercise exceeds the benefits of endurance exercise in ameliorating metabolic dysfunction. Following 8 weeks of diet and exercise interventions, all mice were assessed for their metabolic function by GTT, ITT, and skeletal muscle response of Akt and AS160 phosphorylation to injection of insulin measured by Western blot. (A–C) HOMA-IR taken after an overnight fast for baseline glucose and insulin. (D and E) GTT from 0–120 min and calculated AUC; colored * indicates significant difference from NC-SED. (F and G) ITT from 0–60 min and calculated AUC; colored * indicates significant difference from NC-SED. (H–N) pAkt stimulation, AS160 S318, and AS160 T642 in hindlimb muscles before and after insulin injection and the pre–post ∆ in phosphorylation. (O and P) Total and phosphorylated 4E-BP1. (Q–T) Western results for Raptor, COX4, LC3 II/I, and ubiquitin staining. Representative western blot images inset right. Data presented as mean ± standard error of the mean. Statistical analysis performed by analysis of variance between groups: * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. NC-SED n : 8–16 (white); HFD-SED n : 8–18 (red); HFD-R EX n : 8–16 (blue); HFD-E EX n : 8–15 (green). 4E-BP1 = Eukaryotic translation initiation factor 4E binding protein; Akt = protein kinase B; AS160 = Akt substrate 160; COX4 = cytochrome c oxidase 4; CS = citrate sythase; E EX = endurance exercise; GAPDH = glyceraldehyde 3 phosphate dehydrogenase; GTT = glucose tolerance test; HFD = high fat diet; HOMA-IR = homeostatic model assessment for insulin resistance; iAUC = integrated area under the curve; ITT = insulin tolerance test; LC3 II/I = microtubule-associated protein light chain 3; NC = normal chow; pAkt = phospho-Akt; R EX = resistance exercise; SED = sedentary; Ub = ubiquitin.
Protein Kinase B, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kinase/pmc12816905-99-21-27
Average 86 stars, based on 1 article reviews
protein kinase b - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

99
Cell Signaling Technology Inc protein kinase b akt
miR-136-3p-induced increase in glucose uptake is independent of changes in canonical GLUT4 signaling pathways. The mRNA expression of GLUT4, TBC1D4, and AMPKα in primary human myotubes (A) transfected with miR-136-3p. Representative immunoblot and quantification of (B) AMPKα, (C) TBC1D4, (D) P-TBC1D4, (E) <t>AKT,</t> and (F) P-AKT in primary human myotubes transfected with miR-136-3p and subsequently incubated under basal or insulin-stimulated (120 nM, 1 h) conditions. Insets show representative Western blot image and total ponceau staining for loading control. Results are expressed as mean ± standard error of the mean. * p < 0.05, ** p < 0.005. AKT = protein kinase B; AMPKα = AMP-activated protein kinase α; GLUT4 = glucose transporter 4; miR = microRNA; NC = negative control; ns = no significance; P-AKT = phosphorylated AKT; P-TBC1D4 = phosphorylated TBC1D4; TBC1D4 = Tre-2/BUB2/CDC16 domain family member 4.
Protein Kinase B Akt, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kinase/Akt+Antibody/pmc12811471-130-43-48
Average 99 stars, based on 1 article reviews
protein kinase b akt - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

96
Tocris rho kinase inhibitor y 27 632
miR-136-3p-induced increase in glucose uptake is independent of changes in canonical GLUT4 signaling pathways. The mRNA expression of GLUT4, TBC1D4, and AMPKα in primary human myotubes (A) transfected with miR-136-3p. Representative immunoblot and quantification of (B) AMPKα, (C) TBC1D4, (D) P-TBC1D4, (E) <t>AKT,</t> and (F) P-AKT in primary human myotubes transfected with miR-136-3p and subsequently incubated under basal or insulin-stimulated (120 nM, 1 h) conditions. Insets show representative Western blot image and total ponceau staining for loading control. Results are expressed as mean ± standard error of the mean. * p < 0.05, ** p < 0.005. AKT = protein kinase B; AMPKα = AMP-activated protein kinase α; GLUT4 = glucose transporter 4; miR = microRNA; NC = negative control; ns = no significance; P-AKT = phosphorylated AKT; P-TBC1D4 = phosphorylated TBC1D4; TBC1D4 = Tre-2/BUB2/CDC16 domain family member 4.
Rho Kinase Inhibitor Y 27 632, supplied by Tocris, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kinase/Y-27632+dihydrochloride/pmc13768266-53-10-15
Average 96 stars, based on 1 article reviews
rho kinase inhibitor y 27 632 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

95
BPS Bioscience kinase glo max luminescent assay kit
miR-136-3p-induced increase in glucose uptake is independent of changes in canonical GLUT4 signaling pathways. The mRNA expression of GLUT4, TBC1D4, and AMPKα in primary human myotubes (A) transfected with miR-136-3p. Representative immunoblot and quantification of (B) AMPKα, (C) TBC1D4, (D) P-TBC1D4, (E) <t>AKT,</t> and (F) P-AKT in primary human myotubes transfected with miR-136-3p and subsequently incubated under basal or insulin-stimulated (120 nM, 1 h) conditions. Insets show representative Western blot image and total ponceau staining for loading control. Results are expressed as mean ± standard error of the mean. * p < 0.05, ** p < 0.005. AKT = protein kinase B; AMPKα = AMP-activated protein kinase α; GLUT4 = glucose transporter 4; miR = microRNA; NC = negative control; ns = no significance; P-AKT = phosphorylated AKT; P-TBC1D4 = phosphorylated TBC1D4; TBC1D4 = Tre-2/BUB2/CDC16 domain family member 4.
Kinase Glo Max Luminescent Assay Kit, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kinase/EGFR+Kinase+Assay+Kit/pmc13752819-417-22-27
Average 95 stars, based on 1 article reviews
kinase glo max luminescent assay kit - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

95
BPS Bioscience promising cytotoxic compounds
miR-136-3p-induced increase in glucose uptake is independent of changes in canonical GLUT4 signaling pathways. The mRNA expression of GLUT4, TBC1D4, and AMPKα in primary human myotubes (A) transfected with miR-136-3p. Representative immunoblot and quantification of (B) AMPKα, (C) TBC1D4, (D) P-TBC1D4, (E) <t>AKT,</t> and (F) P-AKT in primary human myotubes transfected with miR-136-3p and subsequently incubated under basal or insulin-stimulated (120 nM, 1 h) conditions. Insets show representative Western blot image and total ponceau staining for loading control. Results are expressed as mean ± standard error of the mean. * p < 0.05, ** p < 0.005. AKT = protein kinase B; AMPKα = AMP-activated protein kinase α; GLUT4 = glucose transporter 4; miR = microRNA; NC = negative control; ns = no significance; P-AKT = phosphorylated AKT; P-TBC1D4 = phosphorylated TBC1D4; TBC1D4 = Tre-2/BUB2/CDC16 domain family member 4.
Promising Cytotoxic Compounds, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kinase/VEGFR2+(KDR)+Kinase+Assay+Kit/pmc13752819-417-2-13
Average 95 stars, based on 1 article reviews
promising cytotoxic compounds - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

99
New England Biolabs reverse oligonucleotides
miR-136-3p-induced increase in glucose uptake is independent of changes in canonical GLUT4 signaling pathways. The mRNA expression of GLUT4, TBC1D4, and AMPKα in primary human myotubes (A) transfected with miR-136-3p. Representative immunoblot and quantification of (B) AMPKα, (C) TBC1D4, (D) P-TBC1D4, (E) <t>AKT,</t> and (F) P-AKT in primary human myotubes transfected with miR-136-3p and subsequently incubated under basal or insulin-stimulated (120 nM, 1 h) conditions. Insets show representative Western blot image and total ponceau staining for loading control. Results are expressed as mean ± standard error of the mean. * p < 0.05, ** p < 0.005. AKT = protein kinase B; AMPKα = AMP-activated protein kinase α; GLUT4 = glucose transporter 4; miR = microRNA; NC = negative control; ns = no significance; P-AKT = phosphorylated AKT; P-TBC1D4 = phosphorylated TBC1D4; TBC1D4 = Tre-2/BUB2/CDC16 domain family member 4.
Reverse Oligonucleotides, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kinase/T4+Polynucleotide+Kinase/pm42977768-372-2-12
Average 99 stars, based on 1 article reviews
reverse oligonucleotides - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

95
BPS Bioscience egfr assay kit
miR-136-3p-induced increase in glucose uptake is independent of changes in canonical GLUT4 signaling pathways. The mRNA expression of GLUT4, TBC1D4, and AMPKα in primary human myotubes (A) transfected with miR-136-3p. Representative immunoblot and quantification of (B) AMPKα, (C) TBC1D4, (D) P-TBC1D4, (E) <t>AKT,</t> and (F) P-AKT in primary human myotubes transfected with miR-136-3p and subsequently incubated under basal or insulin-stimulated (120 nM, 1 h) conditions. Insets show representative Western blot image and total ponceau staining for loading control. Results are expressed as mean ± standard error of the mean. * p < 0.05, ** p < 0.005. AKT = protein kinase B; AMPKα = AMP-activated protein kinase α; GLUT4 = glucose transporter 4; miR = microRNA; NC = negative control; ns = no significance; P-AKT = phosphorylated AKT; P-TBC1D4 = phosphorylated TBC1D4; TBC1D4 = Tre-2/BUB2/CDC16 domain family member 4.
Egfr Assay Kit, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kinase/EGFR+Kinase+Assay+Kit/pmc13764303-230-7-10
Average 95 stars, based on 1 article reviews
egfr assay kit - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

Image Search Results


Transcriptome-wide mapping and biochemical characterization of RhsP2 RNA recognition and ADP-ribosylation. ( A ) Schematic of the eCLIP-seq workflow used to map RhsP2-associated RNAs. Cells expressing FLAG-tagged, catalytically inactive RhsP2* were UV-crosslinked, lysed, and subjected to anti-FLAG immunoprecipitation. Crosslinked RNA fragments associated with RhsP2* were recovered following SDS–PAGE separation, converted into complementary DNA (cDNA) libraries containing unique molecular identifiers, and sequenced. ( B ) Representative genome-browser view of RhsP2* eCLIP-seq signal at a target locus. IP and matched input tracks are shown. The shaded region highlights a representative RhsP2*-enriched peak, with the local sequence shown below. ( C ) Genomic annotation of RhsP2* eCLIP-seq peaks across transcript features. The bar plot shows the fraction of called peaks assigned to CDSs, 5′ UTRs, 3′ UTRs, tRNAs, sRNAs, rRNAs, and intergenic regions. ( D ) De novo motif analysis of RhsP2* eCLIP-seq peaks. Two enriched UAA-centered motifs identified from RhsP2* eCLIP-seq peaks are shown, including a highly enriched UAAG-containing motif. The percentage of peaks containing each motif and the associated enrichment P -value are shown. ( E ) Schematic of the Cy3-labeled synthetic RNA substrate used for biochemical validation and site-mapping experiments. The UAAG motif is highlighted in green, and nucleotide positions used for RNase T1 and alkaline hydrolysis (AH) mapping are indicated. ( F ) Biochemical evaluation of motif-dependent RNA recognition and modification. Top, EMSA evaluating the binding of catalytically inactive RhsP2* to RNA substrates containing the indicated motif variants. RNA substrates were incubated with increasing concentrations of purified RhsP2* (0–10 µM). Free RNA and protein-bound RNA species are indicated. Bottom, in vitro ADP-ribosylation of the corresponding RNA substrates. Reactions were performed with 1 mM NAD⁺ in the absence or presence of 0.1 µM purified WT RhsP2 for 10 s, and reaction products were resolved by denaturing urea-PAGE. Unmodified RNA and slower-migrating ADP-ribosylated RNA (ADPr-RNA) species are indicated. ( G ) AH and RNase T1 mapping of purified ADPr-RNA. Unmodified control RNA (Ctrl) and ADPr-RNA were subjected to AH, and RNase T1 digestion was used as a nucleotide reference ladder. The red AH label denotes the AH lane generated from ADPr-RNA. The green bar marks the UAAG-containing region that is protected from alkaline cleavage following ADP-ribosylation. Numbers indicate nucleotide positions within the synthetic RNA substrate shown in panel (E).

Journal: Nucleic Acids Research

Article Title: An RNA-targeting ADP-ribosyltransferase toxin uncouples mRNA stability from productive translation

doi: 10.1093/nar/gkag1177

Figure Lengend Snippet: Transcriptome-wide mapping and biochemical characterization of RhsP2 RNA recognition and ADP-ribosylation. ( A ) Schematic of the eCLIP-seq workflow used to map RhsP2-associated RNAs. Cells expressing FLAG-tagged, catalytically inactive RhsP2* were UV-crosslinked, lysed, and subjected to anti-FLAG immunoprecipitation. Crosslinked RNA fragments associated with RhsP2* were recovered following SDS–PAGE separation, converted into complementary DNA (cDNA) libraries containing unique molecular identifiers, and sequenced. ( B ) Representative genome-browser view of RhsP2* eCLIP-seq signal at a target locus. IP and matched input tracks are shown. The shaded region highlights a representative RhsP2*-enriched peak, with the local sequence shown below. ( C ) Genomic annotation of RhsP2* eCLIP-seq peaks across transcript features. The bar plot shows the fraction of called peaks assigned to CDSs, 5′ UTRs, 3′ UTRs, tRNAs, sRNAs, rRNAs, and intergenic regions. ( D ) De novo motif analysis of RhsP2* eCLIP-seq peaks. Two enriched UAA-centered motifs identified from RhsP2* eCLIP-seq peaks are shown, including a highly enriched UAAG-containing motif. The percentage of peaks containing each motif and the associated enrichment P -value are shown. ( E ) Schematic of the Cy3-labeled synthetic RNA substrate used for biochemical validation and site-mapping experiments. The UAAG motif is highlighted in green, and nucleotide positions used for RNase T1 and alkaline hydrolysis (AH) mapping are indicated. ( F ) Biochemical evaluation of motif-dependent RNA recognition and modification. Top, EMSA evaluating the binding of catalytically inactive RhsP2* to RNA substrates containing the indicated motif variants. RNA substrates were incubated with increasing concentrations of purified RhsP2* (0–10 µM). Free RNA and protein-bound RNA species are indicated. Bottom, in vitro ADP-ribosylation of the corresponding RNA substrates. Reactions were performed with 1 mM NAD⁺ in the absence or presence of 0.1 µM purified WT RhsP2 for 10 s, and reaction products were resolved by denaturing urea-PAGE. Unmodified RNA and slower-migrating ADP-ribosylated RNA (ADPr-RNA) species are indicated. ( G ) AH and RNase T1 mapping of purified ADPr-RNA. Unmodified control RNA (Ctrl) and ADPr-RNA were subjected to AH, and RNase T1 digestion was used as a nucleotide reference ladder. The red AH label denotes the AH lane generated from ADPr-RNA. The green bar marks the UAAG-containing region that is protected from alkaline cleavage following ADP-ribosylation. Numbers indicate nucleotide positions within the synthetic RNA substrate shown in panel (E).

Article Snippet: Following RNase I treatment and stringent washing, the bead-bound RNA fragments were treated with T4 Polynucleotide Kinase (PNK, NEB) to coordinate the RNA ends for ligation.

Techniques: Cross-linking Immunoprecipitation, Expressing, Immunoprecipitation, SDS Page, Sequencing, Analysis, Labeling, Biomarker Discovery, Modification, Binding Assay, Incubation, Purification, In Vitro, Urea-PAGE, Control, Generated, cDNA Library Assay

Resistance exercise exceeds the benefits of endurance exercise in ameliorating metabolic dysfunction. Following 8 weeks of diet and exercise interventions, all mice were assessed for their metabolic function by GTT, ITT, and skeletal muscle response of Akt and AS160 phosphorylation to injection of insulin measured by Western blot. (A–C) HOMA-IR taken after an overnight fast for baseline glucose and insulin. (D and E) GTT from 0–120 min and calculated AUC; colored * indicates significant difference from NC-SED. (F and G) ITT from 0–60 min and calculated AUC; colored * indicates significant difference from NC-SED. (H–N) pAkt stimulation, AS160 S318, and AS160 T642 in hindlimb muscles before and after insulin injection and the pre–post ∆ in phosphorylation. (O and P) Total and phosphorylated 4E-BP1. (Q–T) Western results for Raptor, COX4, LC3 II/I, and ubiquitin staining. Representative western blot images inset right. Data presented as mean ± standard error of the mean. Statistical analysis performed by analysis of variance between groups: * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. NC-SED n : 8–16 (white); HFD-SED n : 8–18 (red); HFD-R EX n : 8–16 (blue); HFD-E EX n : 8–15 (green). 4E-BP1 = Eukaryotic translation initiation factor 4E binding protein; Akt = protein kinase B; AS160 = Akt substrate 160; COX4 = cytochrome c oxidase 4; CS = citrate sythase; E EX = endurance exercise; GAPDH = glyceraldehyde 3 phosphate dehydrogenase; GTT = glucose tolerance test; HFD = high fat diet; HOMA-IR = homeostatic model assessment for insulin resistance; iAUC = integrated area under the curve; ITT = insulin tolerance test; LC3 II/I = microtubule-associated protein light chain 3; NC = normal chow; pAkt = phospho-Akt; R EX = resistance exercise; SED = sedentary; Ub = ubiquitin.

Journal: Journal of Sport and Health Science

Article Title: Weightlifting outperforms voluntary wheel running for improving adiposity and insulin sensitivity in obese mice

doi: 10.1016/j.jshs.2025.101100

Figure Lengend Snippet: Resistance exercise exceeds the benefits of endurance exercise in ameliorating metabolic dysfunction. Following 8 weeks of diet and exercise interventions, all mice were assessed for their metabolic function by GTT, ITT, and skeletal muscle response of Akt and AS160 phosphorylation to injection of insulin measured by Western blot. (A–C) HOMA-IR taken after an overnight fast for baseline glucose and insulin. (D and E) GTT from 0–120 min and calculated AUC; colored * indicates significant difference from NC-SED. (F and G) ITT from 0–60 min and calculated AUC; colored * indicates significant difference from NC-SED. (H–N) pAkt stimulation, AS160 S318, and AS160 T642 in hindlimb muscles before and after insulin injection and the pre–post ∆ in phosphorylation. (O and P) Total and phosphorylated 4E-BP1. (Q–T) Western results for Raptor, COX4, LC3 II/I, and ubiquitin staining. Representative western blot images inset right. Data presented as mean ± standard error of the mean. Statistical analysis performed by analysis of variance between groups: * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. NC-SED n : 8–16 (white); HFD-SED n : 8–18 (red); HFD-R EX n : 8–16 (blue); HFD-E EX n : 8–15 (green). 4E-BP1 = Eukaryotic translation initiation factor 4E binding protein; Akt = protein kinase B; AS160 = Akt substrate 160; COX4 = cytochrome c oxidase 4; CS = citrate sythase; E EX = endurance exercise; GAPDH = glyceraldehyde 3 phosphate dehydrogenase; GTT = glucose tolerance test; HFD = high fat diet; HOMA-IR = homeostatic model assessment for insulin resistance; iAUC = integrated area under the curve; ITT = insulin tolerance test; LC3 II/I = microtubule-associated protein light chain 3; NC = normal chow; pAkt = phospho-Akt; R EX = resistance exercise; SED = sedentary; Ub = ubiquitin.

Article Snippet: Primary antibodies used for analysis were from Cell Signaling Technologies (Danvers, MA, USA) and diluted 1:1000 unless otherwise stated as follows: protein kinase B (Akt; 1:500; #4691; Cell Signaling Technologies), phospho-Akt (pAkt) S473 (1:500; #9271; Cell Signaling Technologies), Ubiquitin (#3933; Cell Signaling Technologies), microtubule-associated protein light chain 3 (LC3 II/I; #4018; Cell Signaling Technologies), cytochrome c oxidase subunit 4(COX4; #11967; Cell Signaling Technologies), Akt substrate 160 (AS160 S318; #8619; Cell Signaling Technologies), AS160 T642 (#8881; Cell Signaling Technologies), eukaryotic translation initiation factor 4E binding protein (4E-BP1; #9452; Cell Signaling Technologies), and glyceraldehyde 3 phosphate dehydrogenase (GAPDH; #2118; Cell Signaling Technologies).

Techniques: Phospho-proteomics, Injection, Western Blot, Muscles, Ubiquitin Proteomics, Staining, Binding Assay

miR-136-3p-induced increase in glucose uptake is independent of changes in canonical GLUT4 signaling pathways. The mRNA expression of GLUT4, TBC1D4, and AMPKα in primary human myotubes (A) transfected with miR-136-3p. Representative immunoblot and quantification of (B) AMPKα, (C) TBC1D4, (D) P-TBC1D4, (E) AKT, and (F) P-AKT in primary human myotubes transfected with miR-136-3p and subsequently incubated under basal or insulin-stimulated (120 nM, 1 h) conditions. Insets show representative Western blot image and total ponceau staining for loading control. Results are expressed as mean ± standard error of the mean. * p < 0.05, ** p < 0.005. AKT = protein kinase B; AMPKα = AMP-activated protein kinase α; GLUT4 = glucose transporter 4; miR = microRNA; NC = negative control; ns = no significance; P-AKT = phosphorylated AKT; P-TBC1D4 = phosphorylated TBC1D4; TBC1D4 = Tre-2/BUB2/CDC16 domain family member 4.

Journal: Journal of Sport and Health Science

Article Title: Exercise training-induced extracellular miR-136-3p modulates glucose uptake and myogenesis through targeting of NRDC in human skeletal muscle

doi: 10.1016/j.jshs.2025.101091

Figure Lengend Snippet: miR-136-3p-induced increase in glucose uptake is independent of changes in canonical GLUT4 signaling pathways. The mRNA expression of GLUT4, TBC1D4, and AMPKα in primary human myotubes (A) transfected with miR-136-3p. Representative immunoblot and quantification of (B) AMPKα, (C) TBC1D4, (D) P-TBC1D4, (E) AKT, and (F) P-AKT in primary human myotubes transfected with miR-136-3p and subsequently incubated under basal or insulin-stimulated (120 nM, 1 h) conditions. Insets show representative Western blot image and total ponceau staining for loading control. Results are expressed as mean ± standard error of the mean. * p < 0.05, ** p < 0.005. AKT = protein kinase B; AMPKα = AMP-activated protein kinase α; GLUT4 = glucose transporter 4; miR = microRNA; NC = negative control; ns = no significance; P-AKT = phosphorylated AKT; P-TBC1D4 = phosphorylated TBC1D4; TBC1D4 = Tre-2/BUB2/CDC16 domain family member 4.

Article Snippet: Membranes were incubated with primary antibodies directed to NRDC (sc-137199; Santa Cruz Biotechnology, Dallas, TX, USA), AMP-activated protein kinase α (AMPKα) (#2532; Cell Signaling Technology, Danvers, MA, USA), Akt substrate of 160 kDa (AS160) (#2670; Cell Signaling Technology), phospho-AS160 (#8730; Cell Signaling Technology), protein kinase B (AKT) (#9272; Cell Signaling Technology), phospho-AKT (Ser473) (#9271; Cell Signaling Technology), or puromycin (MABE343; Merck Burlington, MA, USA).

Techniques: Protein-Protein interactions, Expressing, Transfection, Western Blot, Incubation, Staining, Control, Negative Control